The company provided 2025 guidance for TTR product sales of $1.6 billion to $1.725 billion, representing a 36% growth at the midpoint compared to 2024. This outlook assumes regulatory approval and the ...
13h
Alnylam Pharmaceuticals Inc (ALNY) reports robust financial performance with a 33% revenue growth and outlines strategic ...
India saw the highest FII outflows in the Asia-Pacific region at $8.2 billion year-to-date, far higher than the $0.1–1.3 billion outflows in South Korea, Taiwan, Indonesia, Thailand, Malaysia, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback